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Seattle, Washington; Sendai, Japan; and Beijing, ChinaOBJECTIVES The goal of this prospective study was to evaluate the carotid atherosclerosis score
(CAS) for predicting the development of high-risk plaque features and plaque burden progression.
BACKGROUND Previous studies have shown that carotid intraplaque hemorrhage (IPH) and a dis-
rupted luminal surface (DLS), as identiﬁed by using magnetic resonance imaging, are associated with
greater risk for cerebrovascular events. On the basis of data from a large cross-sectional study, a scoring
system was developed to determine which plaque features are associated with the presence of IPH and
DLS. However, the predictive value of CAS has not been previously tested in a prospective, longitudinal
study.
METHODS A total of 120 asymptomatic subjects with 50% to 79% carotid stenosis underwent ca-
rotid magnetic resonance imaging scans at baseline and 3 years thereafter. Presence of IPH and DLS,
wall volume, maximum wall thickness, and maximum percent lipid-rich necrotic core area were
measured at both time-points. Baseline CAS values were calculated on the basis of previously published
criteria.
RESULTS Of the 73 subjects without IPH or DLS at baseline, 9 (12%) developed 1 or both of these
features during follow-up. There was a signiﬁcant increasing trend between CAS and the development
of new DLS (p < 0.001) and with plaque burden progression (p ¼ 0.03) but not with the development of
new IPH (p ¼ 0.3). Percent carotid stenosis was not signiﬁcantly associated with new DLS (p ¼ 0.2), new
IPH (p ¼ 0.1), or plaque progression (p ¼ 0.6).
CONCLUSIONS CAS was found to have a signiﬁcant increasing relationship with incident DLS
and plaque progression in this prospective study. CAS can potentially provide improved risk stratiﬁ-
cation beyond luminal stenosis. (J Am Coll Cardiol Img 2014;7:366–73) ª 2014 by the American College
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367troke is one of the leading causes of mortality
and morbidity worldwide, and carotidA B B R E V I A T I O N S
A N D A C R O N YM S
AUC = area under the curve
CAS = carotid atherosclerosis
score
CEA = carotid endarterectomy
CI = conﬁdence interval
DLS = disrupted luminal surface
FCR = ﬁbrous cap rupture
IPH = intraplaque hemorrhage
LRNC = lipid-rich necrotic core
MRI = magnetic resonance
imaging
NWI = normalized wall index
WT = wall thicknessatherosclerotic disease is a primary etiologic
factor (1,2). Currently, the risk of stroke
associated with carotid atherosclerosis is stratiﬁed
according to the severity of luminal stenosis (3).
Several large prospective clinical trials (4–6) have
supported intervention with carotid endarterectomy
(CEA) or stenting for symptomatic patients with
>70% stenosis to reduce stroke risk. However, for
symptomatic patients with <70% stenosis and for
asymptomatic patients, stenosis alone may not be a
reliable measure of stroke risk. A growing body of
evidence suggests that plaque composition, as
detected using magnetic resonance imaging (MRI)
rather than luminal narrowing, is the critical factor
governing risk of ischemic cerebrovascular events
originating from the carotid artery (7–12). Specif-
ically, the presence of a disrupted luminal surface
(DLS) (e.g., ﬁbrous cap rupture [FCR], ulceration)
and/or intraplaque hemorrhage (IPH) is indicative of
a high-risk lesion for ischemic events (13–16).
Although results from studies to better charac-
terize carotid atherosclerosis using MRI hold great
promise, progress toward its translation into clinical
practice has been hindered by the complex nature of
analysis of the multicontrast-weighted images. A
simple-to-use method to classify plaque that has
predictive value for carotid lesion progression and
future ischemic events is essential to move the ﬁeld
forward.
In a cross-sectional study of 435 subjects from 4
imaging sites in the United States and China,
Underhill et al. (17) proposed a rapid risk stratiﬁca-
tion strategy, known as the carotid atherosclerosis
score (CAS), based on maximum wall thickness
(WT) and the maximum lipid-rich necrotic core
percentage (%LRNC). Statistical analysis found that
CAS was an accurate predictor for the presence of
IPH and FCR in the test subgroup of this single
time-point study. Furthermore, when compared with
stenosis measured using magnetic resonance angi-
ography, CAS was a stronger classiﬁer of high-risk
features.
Although CAS was successfully designed and
tested in a cross-sectional study (17), it is unclear if
it can predict the development of high-risk plaque
features and plaque burden progression in a pro-
spective, longitudinal study. The goals of theconsultant for Bristol-Myers Squibb, Imagepace, Merck, Boehringer Ingelh
support from the National Institutes of Health and Philips Healthcare. All
relevant to the contents of this paper to disclose.
Manuscript received May 24, 2013; revised manuscript received September 1present study were to: 1) investigate the associations
between the CAS, incident IPH, or DLS and pla-
que burden progression during follow-up; and 2) to
compare CAS and stenosis in risk prediction among
asymptomatic individuals with 50% to 79% carotid
stenosis.
METHODS
Study subjects. Subjects with 50% to 79% carotid
stenosis on at least 1 side consented to be recruited
into this study at the University of Washington
Medical Center and the Veterans Affairs Puget
Sound Health Care Systems. Carotid stenosis was
determined with duplex sonography using the
Strandness criteria (18). The side with greater ste-
nosis was deﬁned as the index artery. All subjects
were asymptomatic with regard to their carotid dis-
ease for the 6 months before recruitment. One hun-
dred twenty subjects underwent a baseline
carotid MRI and follow-up scan 3 years
thereafter.
Subjects with any of the following con-
ditions were excluded: 1) CEA before or
during the study on the index carotid ar-
tery; 2) previous radiation therapy to the
neck; and 3) contraindication to MRI.
MRI. All subjects underwent MRIs at
baseline and at the 3-year follow-up on a
1.5-T scanner (Signa Version 5.8, GE
Healthcare, Milwaukee, Wisconsin) with a
bilateral, 4-element, phased array surface
coil (Pathway MRI, Seattle, Washington).
A multicontrast protocol for carotid MRI
(19) was used to acquire axial images with
the parameters listed in Table 1.
Image analysis. The index arteries of all subjects
were interpreted via consensus opinion by 2 expe-
rienced reviewers who received certiﬁed training
at the Vascular Imaging Laboratory, University
of Washington, Seattle, Washington. Both re-
viewers were blinded to the time-point and clinical
information during image analysis. For each scan,
multicontrast magnetic resonance images were
aligned using the carotid bifurcation as a landmark.
At each registered axial slice, images were graded
for image quality on a 4-point scale in which 1 ¼
poor and 4 ¼ excellent. Slices with image quality
$2 at both time-points were interpreted usingeim, and Pﬁzer. Dr. Hatsukami has received research grant
other authors have reported that they have no relationships
3, 2013, accepted September 19, 2013.
Table 1. Multicontrast MRI Imaging Parameters
T1w T2w PDw TOF
Readout pulse 2D FSE 2D FSE 2D FSE 3D spoiled GRE
TR, ms 800 2,770 2,770 23
TE, ms 10 40 20 3.8
FOV 16  16 16  16 16  16 16  16
Matrix 256  256 256  256 256  256 256  256
Slice thickness, mm 2.0 2.0 2.0 2.0
NEX 2 2 2 2
No. of slices 12 12 12 24
Blood suppression DIR Multislice DIR Multislice DIR Venous in-ﬂow saturation
Slice gap, mm 0 0 0 1.0
Flip angle 90 90 90 35
Scan time, min 8 4 4 4
DIR ¼ double inversion recovery; FOV ¼ ﬁeld of view; FSE ¼ fast spin echo; GRE ¼ gradient recalled echo;
MRI ¼ magnetic resonance imaging; NEX ¼ number of excitations; PDw ¼ proton density-weighted;
T1w ¼ T1-weighted; T2w ¼ T2-weighted; TE ¼ echo time; TOF ¼ time-of-ﬂight; TR ¼ repetition time.
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368vascular image analysis software (CASCADE,
Vascular Imaging Laboratory, University of
Washington) (20). After drawing the lumen and
outer wall boundaries on each slice, plaque burden
measurements were derived, including wall areaTable 2. Summary of Patient Demographic Characteristics
and Baseline Plaque Burden at Baseline (N [ 73)
Value Range
Age, yrs 70.3  9.6 45–89
Body mass index, kg/m2* 27.7  5.4 18.9–54.3
Systolic blood pressure, mm Hg* 144  21 99–194
Male 62 (85) –
Smoking status*
Never smoked 10 (14) –
Quit 37 (51) –
Active 25 (35) –
Diabetes mellitus* 19 (26) –
History of coronary artery disease* 31 (46) –
History of hypertension 62 (85) –
History of hypercholesterolemia 61 (84) –
Statin therapy 51 (70) –
Carotid stenosis, %y 29  21 0–77
Wall volume, mm3 660  228 249–1,327
Mean normalized wall index 0.52  8.00 0.36–0.74
Maximum wall thickness 3.4  1.2 1.3–7.7
Values are mean  SD or n (%). *Excluding subjects missing measurement: 7
for body mass index, 1 for smoking status, and 5 for history of coronary artery
disease. yMeasured from 3-dimensional time-of-ﬂight magnetic resonance
angiography using the NASCET (North American Symptomatic Carotid End-
arterectomy Trial) criteria.and volume, maximum WT, and mean normalized
wall index (NWI). NWI was computed per slice as:
wall area/(lumen area þ wall area). Based on vali-
dated analysis criteria (21–23), IPH, LRNC, FCR,
and ulceration were identiﬁed. The %LRNC was
also recorded per slice, where %LRNC ¼ 100% 
(LRNC area/wall area). Using the carotid bifur-
cation as a landmark, scans from the 2 time-points
were matched, and artery-based measurements
were computed from the common coverage for
each subject. The inter-reader and interscan
reproducibility of these measurements has been
reported in previous studies (24,25).
The severity of carotid stenosis was quantiﬁed
based on magnetic resonance angiography images
rendered from time-of-ﬂight data by a trained
reviewer who was blinded to clinical information
and cross-sectional carotid magnetic resonance im-
ages. Luminal stenosis was measured on the index
side of the carotid artery using the NASCET
(North American Symptomatic Carotid Endarter-
ectomy Trial) criteria: 1 – (luminal diameter at the
location with maximal narrowing/luminal diameter
of normal distal internal carotid artery)  100% (4).
All measurements were acquired on maximum in-
tensity projection images with CASCADE.
CAS was computed from the maximum WT and
maximum %LRNC measurements, in which maxi-
mum %LRNC represented the cross-sectional slice
with the largest %LRNC value for the index carotid
artery. CAS was determined as follows: CAS ¼ 1
if maximum WT #2 mm; otherwise, if maximum
WT >2 mm, CAS was set according to maximum
%LRNC; CAS ¼ 2 if maximum %LRNC was
<20%, CAS ¼ 3 if maximum %LRNC was
between 20% and 40%, and CAS ¼ 4 if maximum
%LRNC was >40%.
Statistical analysis. Plaque variables were aggregated
over the slices within each artery, in which only slices
present in scans at both time-points were included.
Arteries with <10 mm of common coverage were
excluded. Patient demographic characteristics were
summarized using mean  SD and range for
continuous measurements and count (percentages)
for categorical variables. The chi-square test for
trend was used to test for an increasing association
between CAS and new high-risk features.
Plaque progression was deﬁned as the annualized
wall volume change between time-points. Subjects
who developed ulcerations over the follow-up period
were excluded from the analysis of plaque progres-
sion because morphology measurements (lumen
and wall volumes) were confounded by the presence
of ulceration. Plaque progression was summarized
Table 3. Incidence of New DLS or IPH According to Baseline
CAS (73 Subjects Without DLS or IPH at Baseline)
Baseline CAS n (%)*
n (%)y
DLS IPH DLS or IPH
1 8 (11) 0 (0) 0 (0) 0 (0)
2 51 (70) 0 (0) 2 (4) 2 (4)
3 10 (14) 4 (40) 2 (20) 4 (40)
4 4 (5) 3 (75) 0 (0) 3 (75)
All 73 (100) 7 (10) 4 (5) 9 (12)
p for trend test <0.001 0.264 <0.001
*Percentage of total (N ¼ 73). yPercentage of subjects counted in each row
(see second column).
DLS ¼ disrupted luminal surface; IPH ¼ intraplaque hemorrhage.
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369as mean  SD for the whole group and for each
subgroup deﬁned according to the baseline level
of CAS. The progression rate was compared with
0 using the 1-sample Student t test. Linear regres-
sion was used to test for an increasing trend between
the baseline CAS and plaque progression.
Receiver-operating characteristic curves and the
area under the curve (AUC) statistic were used to
summarize the strength of the association between
new DLS or IPH and CAS, carotid stenosis, and
plaque burden (wall volume, mean NWI, andFigure 1. Baseline MRI Demonstrating a CAS 4 Internal Carotid Pla
Baseline magnetic resonance imaging (MRI) (top row) with a large lipid
(bottom row) of the matched cross-section demonstrates ﬁbrous cap
Also note the large increase in internal carotid wall area and decrease
atherosclerosis score; CE-T1W ¼ post-contrast enhanced T1-weighted imaximum WT). Pearson correlation coefﬁcient was
used similarly with the same predictors and plaque
progression as the outcome.
All statistical analyses were performed using R
version 2.11.0 (R Foundation for Statistical Com-
puting, Vienna, Austria). Throughout, 2-tailed tests
were used, with p < 0.05 denoting statistical
signiﬁcance.
RESULTS
Of the 120 subjects recruited, 20 were excluded:
12 with poor image quality at either time-point,
7 with insufﬁcient coverage, and 1 subject who
underwent CEA during the study period. To eval-
uate the association between CAS and incident IPH
and DLS, 73 of 100 subjects without these features
at baseline were analyzed. The mean time interval
between baseline and follow-up scans was 3.0  0.2
years. Demographic information and baseline pla-
que measurements of these 73 subjects are shown in
Table 2.
Incidence of new high-risk features. The incidence
of new DLS or IPH among the 73 subjects without
these features at baseline is summarized in Table 3.
At follow-up, 7 subjects developed DLS (including
2 ulcerations) and 4 developed IPH (2 of whichque With a Large LRNC
-rich necrotic core (LRNC) (yellow arrows). The 3-year follow-up MRI
rupture (white arrow) with intraplaque hemorrhage (pink arrows).
in lumen area. *Lumen of the internal carotid artery. CAS ¼ carotid
mage; T1W ¼ pre-contrast T1-weighted image; TOF ¼ time-of-ﬂight.
Figure 2. Mean Annualized Change in Wall Volume of Subjects Grouped
According to Baseline CAS
The vertical bars represent 1 SD. Abbreviation as in Figure 1.
Table 4. Predicting N





Wall volume 0.58 (0
Mean NWI 0.84 (0
Maximum WT 0.75 (0
*Test for AUC >0.5. p valu
the conﬁdence intervals (
AUC ¼ area under the r
thickness; other abbrevia
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370were coincident with DLS). All new DLS were
found in those with CAS 3 or 4 at baseline (Fig. 1).
There was a signiﬁcant increasing trend for new
DLS with increasing baseline CAS (p < 0.001) but
not with new IPH (p ¼ 0.3).
Plaque progression during follow-up. Two partici-
pants with evidence of new ulceration at follow-up
were excluded from the plaque progression analysis
(1 with baseline CAS ¼ 3 and the other with
CAS ¼ 4). The mean progression rate was 14.6 
23.5 mm3/year (p < 0.001 for comparison with 0)ew DLS or IPH Using a Single Baseline Predictor: CAS, Stenosis,
Measure (Subjects Without DLS or IPH at Baseline)
Outcome













.92–1.00) <0.001 0.68 (0.42–0.94) 0.142 0.86 (0.71–1.00) <0.001
.43–0.88) 0.183 0.74 (0.52–0.96) 0.110 0.69 (0.50–0.89) 0.063
.36–0.81) 0.465 0.74 (0.43–1.00) 0.104 0.59 (0.37–0.81) 0.383
.67–1.00) 0.003 0.78 (0.60–0.95) 0.065 0.84 (0.70–0.99) 0.001
.60–0.90) 0.030 0.78 (0.59–0.97) 0.062 0.76 (0.62–0.90) 0.013
es were computed using an exact method and are therefore more reliable than
CIs), which were computed using an approximation.
eceiver-operating characteristic curve; NWI ¼ normalized wall index; WT ¼ wall
tions as in Table 3.in the remaining 71 subjects. Figure 2 shows the
mean progression rates within the subgroups
deﬁned according to baseline CAS. There was a
signiﬁcant increasing trend by linear regression (p ¼
0.03) between the mean progression rates of 4.7,
13.9, 18.1, and 42.0 mm3/year and baseline CAS 1,
2, 3, and 4, respectively.
Comparison of CAS, carotid stenosis, and plaque
burden measurements in predicting new DLS and
IPH. Receiver-operating characteristic curve analysis
was conducted with new DLS and IPH as outcomes
and baseline CAS, stenosis, and plaque burden (wall
volume, mean NWI, and maximum WT) as pre-
dictors (Table 4). CAS had the highest AUC (0.96
[95% conﬁdence interval (CI): 0.92 to 1.0]) among
predictors for new DLS (Fig. 3), whereas mean
NWI and maximum WT had the highest AUC for
predicting new IPH (0.78, p > 0.06 for both)
(Fig. 4). The AUCs for carotid percent stenosis
were 0.65 (p ¼ 0.2) and 0.74 (p ¼ 0.1) for new
DLS and IPH, respectively. None of the variables
considered were signiﬁcantly associated with new
IPH. When the combined outcome of new DLS or
IPH was examined, CAS had the highest AUC
(0.86 [95% CI: 0.71 to 1.0]), followed closely by
mean NWI (0.84 [95% CI: 0.70 to 0.99]).
Comparison of CAS and severity of carotid stenosis in
predicting plaque burden progression. The corre-
lations between the plaque progression rate and
baseline CAS, stenosis, and plaque burden are
summarized in Table 5. CAS had the highest cor-
relation (r ¼ 0.26 [95% CI: 0.03 to 0.47]), whereas
percent stenosis had the lowest (r ¼ –0.06 [95% CI:
–0.29 to 0.18]). The 3 plaque burden measures had
similar levels of correlation (with progression of r ¼
0.22 to 0.23), but there were only trends toward
signiﬁcance (p < 0.1 for all 3 measures).
D I SCUSS ION
The initial formulation and testing of CAS was
based on data from a cross-sectional study (17).
The serial carotid MRI study reported herein
demonstrates that CAS measures are predictive of
future carotid luminal surface disruption, thus
providing prospective conﬁrmation of the earlier
single time-point study ﬁndings. Furthermore, a
signiﬁcant association was noted between CAS and
plaque progression in asymptomatic patients with
50% to 79% stenosis and who did not have carotid
DLS or IPH at baseline. We caution the reader
against over-interpretation of the data presented
given the relatively low number of events. Never-
theless, the data are promising for a simpliﬁcation
Figure 4. ROC Curves for Individual Predictors of New IPH
IPH ¼ intraplaque hemorrhage; ROC ¼ receiver-operating characteristic;
other abbreviations as in Figures 1 and 3.
Figure 3. Receiver-Operating Characteristic Curves for
Individual Predictors of New DLS
DLS ¼ disrupted luminal surface; NWI ¼ normalized wall index; WT ¼ wall
thickness; other abbreviation as in Figure 1.
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371of carotid risk stratiﬁcation using CAS and provide
strong evidence for conducting future studies that
use a larger study sample to validate these initial
ﬁndings.
Findings from randomized clinical trials indicate
that the beneﬁt of CEA or stenting in this group
of individuals is marginal. However, the further
risk stratiﬁcation offered by CAS has the potential
to target subgroups that may beneﬁt from inter-
vention, although this possibility must be con-
ﬁrmed in a randomized clinical trial. CAS may also
provide a means to identify individuals who would
beneﬁt from more intensive clinical follow-up.
Although reliable multivariate analysis could not
be conducted due to the limited sample size and
event rate, CAS seemed to be more strongly
associated with both plaque progression and new
DLS than percent stenosis. This ﬁnding suggests
that CAS may provide a better assessment of risk
of stroke, beyond the current clinical angiographic
solution, for asymptomatic patients with 50% to
79% stenosis.
Because maximum %LRNC is the major input
variable to CAS, the ﬁnding that CAS is positively
associated with the incidence of new DLS (p <
0.001) is consistent with the relationship between
%LRNC volume and DLS previously reported by
Underhill et al. (26). In the previous study, IPH
was present in nearly 30% of the carotid arteries
at baseline. In the present study, it was shown
that the risk associated with LRNC, as represented
by CAS, holds in the subgroup without IPH at
baseline.
Although baseline CAS predicted incident DLS
during follow-up, its relationship with new IPH was
inconclusive. There were only 4 incidences of new
IPH, and a positive association between CAS and
new IPH was not found. However, all of the new
episodes of IPH occurred in subjects with CAS 2
and 3 at baseline. For subjects with CAS 4, 78% of
them had IPH already at baseline. Although a
conclusion cannot be drawn from the small number
of events seen here, this ﬁnding may suggest that
IPH tends to occur at an earlier stage of plaque
development and leads to growth into the higher
levels of CAS, which is consistent with the concept
of IPH as a primary driver of plaque growth, as
shown previously (27,28).
The magnetic resonance plaque burden measure
(mean NWI) seemed to predict new DLS or plaque
progression well, although not better than CAS.
During the original development of CAS, mean
NWI was not considered, although maximum NWI
was, as well as maximum WT and other plaqueburden measures. In that cross-sectional analysis,
maximum %LRNC area was more strongly associ-
ated with DLS and IPH than any plaque burden
Table 5. Univariate Correlations Between Plaque Progression
Over 3 Years and Baseline CAS, Stenosis, and Plaque Burden
(71 Subjects Who Did Not Develop Ulceration Over Follow-Up)
r (95% CI) p Value
CAS 0.26 (0.03 to 0.47) 0.026
Stenosis 0.06 (0.29 to 0.18) 0.641
Wall volume 0.22 (-0.02 to 0.43) 0.069
Mean NWI 0.23 (-0.01 to 0.44) 0.057
Maximum WT 0.22 (-0.01 to 0.43) 0.060
r ¼ Pearson correlation coefﬁcient; other abbreviations as in Table 4.
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372measures, and thus CAS was based primarily on
LRNC rather than plaque burden. From a biolog-
ical perspective, it is expected that CAS, which is
based on the presence and size of the LRNC, will
provide a more precise measure of risk for plaque
disruption than mean NWI, which is based solely
on plaque size. For large plaques that are predom-
inantly ﬁbrotic or calciﬁed, the risk for disruption
predicted according to mean NWI may vary from
CAS. Future prospective studies may consider mean
NWI as an additional predictor to conﬁrm that this
ﬁnding holds longitudinally.
Study limitations. The size of the study sample was
not large, and subjects were recruited from only
2 related centers. Furthermore, the rate of new
events and the prevalence of CAS 4 in subjects
without DLS or IPH were small, which also pre-
vented reliable multivariate analysis to statistically
compare the different potential predictors. In addi-
tion, the association between the development of
neurological symptoms and CAS could not be
assessed due to the study design, which required
subjects to have completed both a baseline and a
3-year follow-up MRI of their plaques. Clinical
guidelines at the recruitment centers indicate CEAfor patients with 50% to 79% stenosis according to
ultrasound who become symptomatic, and thus no
follow-upMRI was available in those cases. A larger,
multicenter study is needed to have sufﬁcient power
to assess the ability of CAS for prediction of future
ischemic events. Finally, 17% of patients were
excluded in this study due to imaging issues. Three-
dimensional MRI techniques such as 3D-MERGE
and SNAP (29,30) have been recently developed
that will reduce the percentage of excluded subjects
in future studies. Advantages of these new tech-
niques include: 1) larger ﬁeld of view and isotropic
3-dimensional scans that will improve coregistration
of serially acquired scans and reduce the number
of cases excluded due to insufﬁcient coverage;
2) shorter scan time, which may reduce exclusions
due to motion artifact; 3) decreased artifact due to
low ﬂow; and 4) higher contrast between IPH,
surrounding vessel wall, and lumen.CONCLUS IONS
CAS, on the basis of 2 plaque parameters
(maximum WT and %LRNC), was found to have a
signiﬁcant increasing relationship with incident
DLS and plaque progression in this prospective,
longitudinal study of subjects with asymptomatic,
50% to 79% carotid stenosis. The CAS concept
provides a method to further stratify risk beyond
luminal stenosis and may allow more effective tar-
geting of patients for speciﬁc treatment to prevent
future stroke.
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